EDUARDO JOSÉ
GUTIÉRREZ RIVAS
Investigador en el periodo 2009-2011
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (19)
2020
-
Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease
Neurologia, Vol. 35, Núm. 3, pp. 185-206
-
Clinical, pathological and genetic spectrum in 89 cases of mitochondrial progressive external ophthalmoplegia
Journal of Medical Genetics, Vol. 57, Núm. 9, pp. 643-646
2019
-
Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease
Medicina Clinica, Vol. 153, Núm. 2, pp. 82.e1-82.e17
2015
-
The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: Data from individual patients and family studies
Molecular Genetics and Metabolism, Vol. 114, Núm. 2, pp. 248-258
2012
-
Genotype and phenotype study of 34 Spanish patients diagnosed with oculopharyngeal muscular dystrophy
Journal of Neurology, Vol. 259, Núm. 8, pp. 1546-1552
-
Guía clínica de la enfermedad de pompe de inicio tardío
Revista de Neurologia, Vol. 54, Núm. 8, pp. 497-507
-
Screening for mutations in Spanish families with myotonia. Functional analysis of novel mutations in CLCN1 gene
Neuromuscular Disorders, Vol. 22, Núm. 3, pp. 231-243
2010
-
Chemotherapy-induced peripheral neuropathy: Clinical features, diagnosis, prevention and treatment strategies
Clinical and Translational Oncology, Vol. 12, Núm. 2, pp. 81-91
-
Latency values of 248 H reflexes in 124 normal subjects
Revista de Neurologia, Vol. 51, Núm. 10, pp. 589-591
-
Non-dystrophic myotonias. Diagnostic approach in a case related with a mutation in the sodium-channel gene
Revista de Neurologia
2007
-
Controversias éticas sobre la utilización de placebo como tratamiento control en los ensayos clínicos en neurología
Neurologia, Vol. 22, Núm. 2, pp. 106-113
-
Double trouble (McArdle's disease and myasthenia gravis): How can exercise help?
Muscle and Nerve, Vol. 35, Núm. 1, pp. 125-128
2004
-
Coenzyme Q 10 improves lactic acidosis, strokelike episodes, and epilepsy in a patient with MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes)
Clinical Neuropharmacology, Vol. 27, Núm. 4, pp. 187-191
2000
-
Chronic paroxysmal hemicrania-tic syndrome
Headache, Vol. 40, Núm. 8, pp. 682-685
1998
-
Neuralgia amiotrofica: Revision de 37 casos
Revista de Neurologia, Vol. 27, Núm. 159, pp. 823-826
1995
-
Clinical heterogeneity in two pedigrees with the 3243 bp tRNALeu(UUR) mutation of mitochondrial DNA
Acta Neurologica Scandinavica, Vol. 91, Núm. 1, pp. 62-65
1994
-
Variable clinical expression associated with the mutation 3243 np of mitochondrial DNA
Journal of Inherited Metabolic Disease, Vol. 17, Núm. 5, pp. 634-635
1993
-
Mitochondrial myopathies
Anales de medicina interna (Madrid, Spain : 1984), Vol. 10 Suppl, pp. 21-27
-
Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson disease
Clinical Chemistry, Vol. 39, Núm. 4, pp. 667-669